Form 8K ABVC Biopharma Inc For: 12 August
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ABVC Biopharma Inc (ABVC)
ABVC Biopharma Inc stock price live, this page displays NASDAQ ABVC stock exchange data. View the ABVC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ABVC Biopharma Inc real time stock price chart below.
What Is the ABVC Biopharma Inc Stock Price Today?
The ABVC Biopharma Inc stock price today is 0.8849.
What Is the Stock Symbol for ABVC Biopharma Inc?
The stock symbol for ABVC Biopharma Inc is "ABVC."
What Stock Exchange Does ABVC Biopharma Inc Trade On?
ABVC Biopharma Inc is listed and trades on the NASDAQ stock exchange.
Is ABVC Biopharma Inc a Good Stock to Buy?
Determining whether ABVC Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABVC quote. (ISIN: US00091F3047)
What Is the ABVC Biopharma Inc Stock Price Today?
The ABVC Biopharma Inc stock price today is 0.8849.
What Is the Stock Symbol for ABVC Biopharma Inc?
The stock symbol for ABVC Biopharma Inc is "ABVC."
What Stock Exchange Does ABVC Biopharma Inc Trade On?
ABVC Biopharma Inc is listed and trades on the NASDAQ stock exchange.
Is ABVC Biopharma Inc a Good Stock to Buy?
Determining whether ABVC Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABVC quote. (ISIN: US00091F3047)
0.8849
+0.0204(+2.36%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8750
0.8900
52 wk Range
0.7069
3.4000
ABVC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.87500.8900
52 wk Range
0.70693.4000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABVC Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Form 8K ABVC Biopharma Inc For: 30 October- Investing.com
- Form 8K ABVC Biopharma Inc For: 12 August
- Investing.com
- Form 8K ABVC Biopharma Inc For: 27 March
- Investing.com
Form 8K ABVC Biopharma Inc For: 3 November- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Earnings
Latest Release
Aug 12, 2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
-- / --
Compare ABVC to Peers and Sector
Metrics to compare | ABVC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABVCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.2x | −9.1x | −0.4x | |
PEG Ratio | −1.40 | 0.00 | 0.00 | |
Price/Book | 2.2x | 5.6x | 2.6x | |
Price / LTM Sales | - | 24.2x | 3.1x | |
Upside (Analyst Target) | - | 46.7% | 49.0% | |
Fair Value Upside | Unlock | −7.4% | 7.1% | Unlock |
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. The company has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the ABVC Biopharma (ABVC) Stock Price Today?
The ABVC Biopharma stock price today is 0.8849 USD.
What Stock Exchange Does ABVC Biopharma Trade On?
ABVC Biopharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for ABVC Biopharma?
The stock symbol for ABVC Biopharma is "ABVC."
What Is the ABVC Biopharma Market Cap?
As of today, ABVC Biopharma market cap is 22.4100M USD.
What Is ABVC Biopharma's Earnings Per Share (TTM)?
The ABVC Biopharma EPS (TTM) is -0.2855.
From a Technical Analysis Perspective, Is ABVC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has ABVC Biopharma Stock Split?
ABVC Biopharma has split 3 times.
What is the current trading status of ABVC Biopharma (ABVC)?
As of Sep 03, 2026, ABVC Biopharma (ABVC) is trading at a price of 0.8849 USD, with a previous close of 0.8645 USD. The stock has fluctuated within a day range of 0.8750 USD to 0.8900 USD, while its 52-week range spans from 0.7069 USD to 3.4000 USD.
What Is the ABVC Premarket Price?
ABVC's last pre-market stock price is 0.7800 USD. The pre-market share volume is 140.0000, and the stock has decreased by -0.0845, or -9.7700%.
What Is the ABVC After Hours Price?
ABVC's last after hours stock price is 0.7854 USD, the stock has decreased by -0.0791, or -9.1500%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.